Brain biopsy in AIDS patients: diagnostic yield and treatment applications

Table 1 Patients demographic and clinical data

	Diagnosis	Age	SBX VS open	Sex	Solitary vs multiple	Target location	Side	Enhancement	Edema	Presenting symptoms	CD4 pre biopsy	Treatment	Complications	Clinical improvement
1	PML	37	sbx	Male	Multiple	BG	Right	No	None	Combined	69	AZT, 3TC	No	No
2	Non diagnostic × 1,Toxoplasmosis 2nd	36	sbx	Male	Solitary	Frontal	Right	Yes	Yes	Motor	50	AZT, 3TC, Antitoxoplasmosis	Bleeding	No
3	PML	41	sbx	Male	Solitary	BG	Left	No	None	Cognitive	10	AZT, 3TC	No	No
4	Lymphoma	39	sbx	Male	Solitary	BG	Right	Yes	yes	Motor	13	Radiation Therapy	No	Yes
5	PML	32	sbx	Male	Multiple	Frontal	Right	No	None	Combined	57	HAART	No	Yes
6	Toxoplasmosis	24	sbx	Male	Multiple	BG	Left	Yes	Yes	Combined	38	HAART, Antitoxoplasmosis	No	No
7	Toxoplasmosis	29	sbx	Male	Solitary	Frontal	Right	Yes	Yes	Motor	185	HAART, Antitoxoplasmosis	No	Yes
8	Non Diagnostic × 2 Aspergilosis 3rd	78	sbx	Male	Multiple	Parietal occipital frontal	Right	Yes	Yes	Motor	50	HAART, Amphotericin	No	No
9	HIV encephalopathy	33	sbx	Male	Multiple	Occipital	Right	Yes	Yes	Combined	3	HAART	No	Yes
10	PML	48	sbx	Male	Multiple	Frontal	Right	Yes	None	Combined	25	HAART	No	Yes
11	Non diagnostic inflamatory reactive process	41	sbx	Female	Multiple	BG	Left	Yes	Yes	Motor	22	HAART	No	Yes
12	Viral infection	37	sbx	Male	Multiple	Frontal	Left	Yes	Yes	Combined	36	HAART	No	No
13	Cryptoccocal	55	sbx	male	Multiple	Temporal	Left	Yes	Yes	Motor	60	HAART, Amphotericin, Intraconazol	No	No
14	Viral infection	46	sbx	Female	Multiple	Occipital	Right	No	None	Combined	338	HAART	No	Yes
15	Viral infection	46	sbx	Female	Multiple	BG	Right	Yes	Yes	Combined	33	HAART	Bleeding	No
16	Toxoplasmosis	32	open	Female	Multiple	Parietal	Right	Yes	Yes	Combined	14	HAART, Antitoxoplasmosis	No	Yes

ISSN: 1742-6405